about
Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity.Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onsetA combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathologyConverging evidence of blood-based biomarkers for schizophrenia: an update.The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.Applications of blood-based protein biomarker strategies in the study of psychiatric disorders.The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia.Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles.Blood-based immune-endocrine biomarkers of treatment response in depression.Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis.Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical Approach.Associations between SNPs and immune-related circulating proteins in schizophrenia.Serum biomarkers predictive of depressive episodes in panic disorder.Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder.Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy.Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected ChildrenEvidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patientsPredictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand
P50
Q33424181-43CED7A8-0130-4E5E-9C46-12A7FC875E9CQ34484906-F2BC390F-221B-48CC-97B7-EE30C8C44816Q37235856-F9AF9CEA-2386-4D2C-B0A8-4AE363EBE8F7Q37952390-DBFE3F22-AA7B-4DA5-986F-CEC5ADBBDDCAQ38170139-6310A111-9EBA-4D9D-9AD5-D29C604767B2Q38244876-3E9A23F4-A125-430C-A6B6-F89670C293A7Q38446078-D409FB80-E3E9-4C3A-ACC8-987E37C0D247Q38628494-6E8DD117-A09A-4C52-9D7C-E42C55B840EBQ38815656-5285BB0D-469D-42A1-B3B4-22783C941E3BQ38933936-3F17B8BC-EABA-4CD5-A74D-5E2D1779BADCQ40308719-81BFA415-AB6F-4146-A4F2-3BACCDB563B2Q42002123-FE05231B-522A-4BD3-B20A-8EF1BA0DF0F1Q48068093-06D734F9-30D6-4ECD-ACEF-3015A6665729Q48084166-56CB9C3E-52BB-4EC9-B9C3-ACD073EC231DQ48162795-DA063A6B-2942-42A5-8F00-009BF9686C5DQ48279685-BA627F43-5DD8-45D2-9A47-10D01C7895DCQ52641467-B4A744DA-B455-4DC2-95F6-2C4744D3118AQ57140492-C3E10E78-DAD7-43C8-A4F5-43B7649BDD06Q60649876-676AC2D5-6CDB-4601-92EA-ABA4EE5CDE84Q91450020-2401987F-F889-4160-9E18-3EEC3D4BC6E7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Man Chan
@ast
Man Chan
@en
Man Chan
@es
Man Chan
@nl
type
label
Man Chan
@ast
Man Chan
@en
Man Chan
@es
Man Chan
@nl
prefLabel
Man Chan
@ast
Man Chan
@en
Man Chan
@es
Man Chan
@nl
P106
P214
1883155191923882440003
P31
P496
0000-0002-4866-5170
P7859
viaf-1883155191923882440003